Terumo Corporation

Terumo Corporation is a Japanese medical device company headquartered in Shibuya, Tokyo, Japan, founded in 1921 that manufactures a wide range of medical devices including blood collection systems, infusion therapy products, vascular intervention devices, cardiac surgery equipment, and blood component separation systems. In the research and clinical science context, Terumo's TRIMA Accel and Spectra Optia apheresis systems are extensively used in academic medical centers for both therapeutic apheresis procedures (plasma exchange, cytapheresis) and research applications including the collection of peripheral blood stem cells for hematopoietic stem cell transplantation research and the preparation of mononuclear cell products for immunological studies. Their Optia apheresis platform supports photopheresis procedures used in the research and treatment of graft-versus-host disease and cutaneous T-cell lymphoma. Terumo's Sarstedt-branded blood collection tubes (through partnership) and their own blood collection needle systems are used globally for sample collection in clinical and epidemiological research. Their infusion pump portfolio, including the TE-362 and TE-162 syringe pumps, are standard equipment in intensive care research and animal model studies requiring precisely controlled drug delivery. Terumo's cardiac surgery division provides the Capiox oxygenators and cardiotomy reservoirs used in cardiopulmonary bypass circuits for cardiac surgery research. The company invests in biomaterials research for antithrombogenic coatings on blood-contacting devices, with academic collaborations exploring hemocompatibility mechanisms and surface modification strategies.